Absolute CD3+ CD158k+ lymphocyte count is reliable and more sensitive than cytomorphology to evaluate blood tumour burden in Sézary syndrome

British Journal of Dermatology

Volumn 162, Issue 1, 2010, Pages 123-128

  Bouaziz, J D ^a,b   Remtoula, N ^a   Bensussan, A ^a   Marie Cardine, A ^a   Bagot, M ^a,b  

^a SAINT LOUIS HOSPITAL   (France)

^b HENRI MONDOR HOSPITAL   (France)

Author keywords

CD158k; Cutaneous T cell lymphoma; KIR3DL2; Leukaemia; S zary syndrome

Indexed keywords

KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 3DL2;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CD3+ T LYMPHOCYTE; CELL STRUCTURE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; LYMPHOCYTE COUNT; MALE; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; SEZARY SYNDROME; TUMOR VOLUME;

AGED; AGED, 80 AND OVER; ANTIGENS, CD3; FEMALE; FLOW CYTOMETRY; HUMANS; LYMPHOCYTE COUNT; LYMPHOCYTE SUBSETS; MALE; MIDDLE AGED; RECEPTORS, KIR3DL2; SEZARY SYNDROME; TUMOR BURDEN; TUMOR MARKERS, BIOLOGICAL;

EID: 72749105638     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2009.09364.x     Document Type: Article

References (20)

1. Willemze R, Jaffe ES, Burg G et al. WHO-EORTC classification for cutaneous lymphomas. Blood 2005 105 : 3768 3785.
2. Morice WG, Katzmann JA, Pittelkow MR et al. A comparison of morphologic features, flow cytometry, TCR-Vbeta analysis, and TCR-PCR in qualitative and quantitative assessment of peripheral blood involvement by Sézary syndrome. Am J Clin Pathol 2006 125 : 364 374.
3. Lutzner MA, Emerit I, Durepaire R et al. Cytogenetic, cytophotometric, and ultrastructural study of large cerebriform cells of the Sézary syndrome and description of a small-cell variant. J Natl Cancer Inst 1973 50 : 1145 1162.
4. van der Loo EM, Cnossen J, Meijer CJ. Morphological aspects of T cell subpopulations in human blood: characterization of the cerebriform mononuclear cells in healthy individuals. Clin Exp Immunol 1981 43 : 506 516.
5. Duncan SC, Winkelmann RK. Circulating Sézary cells in hospitalized dermatology patients. Br J Dermatol 1978 99 : 171 178.
6. Vonderheid EC, Bernengo MG, Burg G et al. Update on erythrodermic cutaneous T-cell lymphoma: report of the International Society for Cutaneous Lymphomas. J Am Acad Dermatol 2002 46 : 95 106.
7. Vonderheid EC, Bigler RD, Kotecha A et al. Variable CD7 expression on T cells in the leukemic phase of cutaneous T cell lymphoma (Sézary syndrome). J Invest Dermatol 2001 117 : 654 662.
8. Jones D, Dang NH, Duvic M et al. Absence of CD26 expression is a useful marker for diagnosis of T-cell lymphoma in peripheral blood. Am J Clin Pathol 2001 115 : 885 892.
9. Kelemen K, Guitart J, Kuzel TM et al. The usefulness of CD26 in flow cytometric analysis of peripheral blood in Sézary syndrome. Am J Clin Pathol 2008 129 : 146 156.
10. Klemke CD, Brade J, Weckesser S et al. The diagnosis of Sézary syndrome on peripheral blood by flow cytometry requires the use of multiple markers. Br J Dermatol 2008 159 : 871 880.
11. Bagot M, Moretta A, Sivori S et al. CD4(+) cutaneous T-cell lymphoma cells express the p140-killer cell immunoglobulin-like receptor. Blood 2001 97 : 1388 1391.
12. Poszepczynska-Guigne E, Schiavon V, D'Incan M et al. CD158k/KIR3DL2 is a new phenotypic marker of Sézary cells: relevance for the diagnosis and follow-up of Sézary syndrome. J Invest Dermatol 2004 122 : 820 823.
13. Pende D, Biassoni R, Cantoni C et al. The natural killer cell receptor specific for HLA-A allotypes: a novel member of the p58/p70 family of inhibitory receptors that is characterized by three immunoglobulin-like domains and is expressed as a 140-kD disulphide-linked dimer. J Exp Med 1996 184 : 505 518.
14. Moretta A, Biassoni R, Bottino C et al. Major histocompatibility complex class I-specific receptors on human natural killer and T lymphocytes. Immunol Rev 1997 155 : 105 117.
15. Ortonne N, Le Gouvello S, Mansour H et al. CD158K/KIR3DL2 transcript detection in lesional skin of patients with erythroderma is a tool for the diagnosis of Sézary syndrome. J Invest Dermatol 2008 128 : 465 472.
16. Bahler DW, Hartung L, Hill S et al. CD158k/KIR3DL2 is a useful marker for identifying neoplastic T-cells in Sézary syndrome by flow cytometry. Cytometry B Clin Cytom 2008 74 : 156 162.
17. Scarisbrick JJ, Whittaker S, Evans AV et al. Prognostic significance of tumor burden in the blood of patients with erythrodermic primary cutaneous T-cell lymphoma. Blood 2001 97 : 624 630.
18. van Bergen J, Thompson A, van der Slik A et al. Phenotypic and functional characterization of CD4 T cells expressing killer Ig-like receptors. J Immunol 2004 173 : 6719 6726.
19. Chwae YJ, Chang MJ, Park SM et al. Molecular mechanism of the activation-induced cell death inhibition mediated by a p70 inhibitory killer cell Ig-like receptor in Jurkat T cells. J Immunol 2002 169 : 3726 3735.
20. Marie-Cardine A, Huet D, Ortonne N et al. Killer cell Ig-like receptors CD158a and CD158b display a coactivatory function, involving the c-Jun NH2-terminal protein kinase signaling pathway, when expressed on malignant CD4+ T cells from a patient with Sézary syndrome. Blood 2007 109 : 5064 5065.